Novo CEO pressed by Senate to chop prices of weight problems, diabetes medication CEO Lars Fruergaard Jørgensen instructed lawmakers the company would contemplate new talks with insurers with regards to the record costs of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies. Elevance https://rafaelvldsi.azzablog.com/30783969/considerations-to-know-about-healthcare-news